Tenet Healthcare Shares Drop After Director Sells $2.63 Million Worth of Stock
Shares of Tenet Healthcare (NYSE:THC) fell by 2.3% in premarket trading after a regulatory filing revealed that director Richard Mark sold $2.63 million worth of stock on September 10, 2026. The sale involved 10,000 shares at an average price of $263.42 per share through multiple transactions ranging from $263.15 to $264.03. Following the transaction, Mark still holds a total of 25,121 beneficially owned shares in Tenet Healthcare. The sale was executed via an attorney-in-fact arrangement involving Chad J. Wiener. No specific reason for the insider selling activity was disclosed in the filing, and it remains unclear whether this reflects any negative sentiment about the company's future prospects. Tenet operates hospitals and healthcare facilities across the U.S., and such insider sales can sometimes influence investor confidence depending on context.
Tickers: $THC
Topics: healthcare stocks tenet healthcare